The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 19, 2023

Filed:

Feb. 28, 2014
Applicant:

Otsuka Pharmaceutical Co., Ltd., Tokyo, JP;

Inventors:

Akitsuna Akagi, Osaka, JP;

Kai Suzuki, Osaka, JP;

Atsuya Nakamura, Osaka, JP;

Toru Nishibayashi, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); A61K 47/38 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 47/26 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/55 (2013.01); A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A61K 9/10 (2013.01); A61K 9/1652 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01);
Abstract

This invention provides a suspension for oral administration comprising particles containing amorphous tolvaptan that can inhibit or delay crystallization of amorphous tolvaptan over time in the suspension, and stably maintain high solubility of tolvaptan and excellent absorbability of tolvaptan from the gastrointestinal tract; and a solid formulation for oral administration that can be suspended to prepare the suspension for oral administration at the time of use. This invention relates to a suspension for oral administration, in particular, a syrup, comprising (a) particles containing amorphous tolvaptan, (b) hydroxypropyl methylcellulose (HPMC), and (c) a solvent, wherein the amount of the HPMC (b) is 0.1 to 25% by weight based on the total weight of the suspension for oral administration.


Find Patent Forward Citations

Loading…